Trerief zonisamide: Phase II started

Dainippon disclosed in its fiscal 2Q13 earnings for the 6 months ended Sept. 30 that it began a double-blind, placebo-controlled, Japanese Phase II trial to evaluate oral Trerief in about 150 patients...